BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9655979)

  • 1. [FAP-1: a protein tyrosine phosphatase that is involved in Fas-mediated apoptosis].
    Yano H; Sato T
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1193-9. PubMed ID: 9655979
    [No Abstract]   [Full Text] [Related]  

  • 2. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
    Wieckowski E; Atarashi Y; Stanson J; Sato TA; Whiteside TL
    J Cell Biochem; 2007 Jan; 100(1):16-28. PubMed ID: 16888780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fas signaling pathway is functional in colon carcinoma cells and induces apoptosis.
    Houghton JA; Harwood FG; Gibson AA; Tillman DM
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2205-9. PubMed ID: 9815616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of FAP-1 expression and function in thyroid follicular cells.
    Myc A; Arscott PL; Bretz JD; Thompson NW; Baker JR
    Endocrinology; 1999 Nov; 140(11):5431-4. PubMed ID: 10537175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells.
    Tillman DM; Harwood FG; Gibson AA; Houghton JA
    Cell Death Differ; 1998 May; 5(5):450-7. PubMed ID: 10200495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural modification of Fas C-terminal tripeptide and its effects on the inhibitory activity of Fas/FAP-1 binding.
    Sawa E; Takahashi M; Kamishohara M; Tazunoki T; Kimura K; Arai M; Miyazaki T; Kataoka S; Nishitoba T
    J Med Chem; 1999 Aug; 42(17):3289-99. PubMed ID: 10464015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells.
    Vondrácek J; Sheard MA; Krejcí P; Minksová K; Hofmanová J; Kozubík A
    J Leukoc Biol; 2001 May; 69(5):794-802. PubMed ID: 11358989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extinction of insulin-like growth factor-I mitogenic signaling by antiestrogen-stimulated Fas-associated protein tyrosine phosphatase-1 in human breast cancer cells.
    Freiss G; Puech C; Vignon F
    Mol Endocrinol; 1998 Apr; 12(4):568-79. PubMed ID: 9544992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer.
    Meinhold-Heerlein I; Stenner-Liewen F; Liewen H; Kitada S; Krajewska M; Krajewski S; Zapata JM; Monks A; Scudiero DA; Bauknecht T; Reed JC
    Am J Pathol; 2001 Apr; 158(4):1335-44. PubMed ID: 11290551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas.
    Lee SH; Shin MS; Lee JY; Park WS; Kim SY; Jang JJ; Dong SM; Na EY; Kim CS; Kim SH; Yoo NJ
    J Pathol; 1999 Jun; 188(2):207-12. PubMed ID: 10398166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
    Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
    Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells.
    Li Y; Kanki H; Hachiya T; Ohyama T; Irie S; Tang G; Mukai J; Sato T
    Int J Cancer; 2000 Aug; 87(4):473-9. PubMed ID: 10918185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
    Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
    Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combinative effects of FAP-1 antisense oligonucleotide and carboplatin on apoptosis of ovarian cancer cell SKOV3].
    Wang B; Zheng WG; Xin XY; Qi RY; Yu YC; Cao YX
    Ai Zheng; 2004 Aug; 23(8):885-9. PubMed ID: 15301708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.
    Kimber WA; Deak M; Prescott AR; Alessi DR
    Biochem J; 2003 Dec; 376(Pt 2):525-35. PubMed ID: 14516276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-head juxtaposition of Fas-associated phosphatase-1 (FAP-1) and c-Jun NH2-terminal kinase 3 (JNK3) genes: genomic structure and seven polymorphisms of the FAP-1 gene.
    Yoshida S; Harada H; Nagai H; Fukino K; Teramoto A; Emi M
    J Hum Genet; 2002; 47(11):614-9. PubMed ID: 12436199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.
    Bompard G; Puech C; Prébois C; Vignon F; Freiss G
    J Biol Chem; 2002 Dec; 277(49):47861-9. PubMed ID: 12354757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.